MiniMed Expands Medicare Coverage for Compact Insulin Pump System
Event summary
- MiniMed Flex™ system now available to Medicare and Medicare Advantage beneficiaries as of July 22, 2026.
- System is half the size of previous MiniMed pumps, app-controlled, and holds 300 units of insulin.
- SmartGuard™ technology automatically adjusts insulin delivery every five minutes.
- Real-world evidence shows Medicare beneficiaries using similar technology exceeded ADA glycemic targets.
The big picture
This expansion aligns with broader trends in healthcare technology towards more accessible, user-friendly devices for chronic disease management. MiniMed's move to secure Medicare coverage could set a precedent for other medical device companies targeting aging populations. The real-world evidence supporting glycemic outcomes may also influence future reimbursement policies for advanced diabetes technologies.
What we're watching
- Market Expansion
- How the inclusion of Medicare beneficiaries will affect MiniMed's market penetration and revenue growth.
- Technology Adoption
- Whether the app-controlled design will accelerate adoption among older patients familiar with traditional pumps.
- Competitive Dynamics
- The pace at which competitors like Abbott may respond with similar compact, app-integrated insulin pump systems.
Related topics